BOS-172722

BOS-172722 Suppliers list
Company Name: ShangHai Caerulum Pharma Discovery Co., Ltd.  
Tel: 18149758185 18149758185
Email: sales-cpd@caerulumpharma.com
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 177-54423994 17754423994
Email: 2853530910@QQ.com
Company Name: Twochem Co.Ltd.  
Tel: 021-58111628 15800915896
Email: sales@twochem.com
Company Name: Shanghai Benso Pharmaceutical Technology Co., Ltd.  
Tel: 15088289376;13917786310
Email: 248775804@qq.com

BOS-172722 manufacturers

  • BOS-172722 USP/EP/BP
  • BOS-172722 USP/EP/BP pictures
  • $1.10
  • 2026-08-20
  • CAS:1578245-44-9
  • Min. Order: 1g
  • Purity: 99.9%
  • Supply Ability: 100 Tons min
  • BOS-172722
  • BOS-172722 pictures
  • $44.00
  • 2026-07-14
  • CAS:1578245-44-9
  • Purity: 99.79%
  • Supply Ability: 10g
  • BOS-172722
  • BOS-172722 pictures
  • $44.00
  • 2026-07-14
  • CAS:1578245-44-9
  • Purity: 99.79%
  • Supply Ability: 10g
BOS-172722 Basic information
Product Name:BOS-172722
Synonyms:BOS-172722;N2-(2-ethoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl)-6-methyl-N8-neopentylpyrido[3,4-d]pyrimidine-2,8-diamine;Pyrido[3,4-d]pyrimidine-2,8-diamine, N8-(2,2-dimethylpropyl)-N2-[2-ethoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl]-6-methyl-;BOS-172722 USP/EP/BP;autophosphorylation,Inhibitor,breast,cancer,BOS 172722,BOS172722,inhibit,BOS-172722,Monopolar spindle 1,Mps1;BOS-172722, 10 mM in DMSO;BOS172722 ,S8911
CAS:1578245-44-9
MF:C24H30N8O
MW:446.55
EINECS:
Product Categories:
Mol File:1578245-44-9.mol
BOS-172722 Structure
BOS-172722 Chemical Properties
Boiling point 672.2±65.0 °C(Predicted)
density 1.25±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO:5.0(Max Conc. mg/mL);11.19(Max Conc. mM)
1M HCl:65.0(Max Conc. mg/mL);145.56(Max Conc. mM)
form Solid
pka5.83±0.30(Predicted)
color Light yellow to yellow
Safety Information
MSDS Information
BOS-172722 Usage And Synthesis
UsesBOS-172722 is an inhibitor of monopolar spindle 1 (MPS1) checkpoint with an IC50 of 11 nM and 63 nM for MPS1 (1 mM ATP) and P-MPS1, respectively. BOS-172722 also has potential for the study of various forms of breast cancer[1].
in vivo

BOS-172722 shows excellent PK in mouse, rat, and dog[1].
BOS-172722 (50 mg/kg) results in an increased suppression of MPS1 autophosphorylation at 6 and 24 h[1].

Animal Model:Dog[2].
Dosage:1 mg/kg (iv), 5 mg/kg (po) (Pharmacokinetic Analysis).
Administration:IV and PO.
Result:T1/2 = 12 h, Cmaxpo = 7770 nmol/L, AUCpo = 147035 h*nmol/L.
References[1] ARYL SULFONOHYDRAZIDES. WO 2014037750 A1.
Tag:BOS-172722(1578245-44-9) Related Product Information
BOS-172722 4-[[4-Amino-5-cyano-6-[(1,1-dimethylethyl)amino]-2-pyridinyl]amino]benzamide BAY-1217389 N-Cyclopropyl-4-[8-[(2-methylpropyl)amino]-6-(5-quinolinyl)imidazo[1,2-a]pyrazin-3-yl]benzamide NTRC 00660 MPS1-IN-3